Business Wire

Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals

New LC-MS system delivers accurate and reproducible results for multi-attribute monitoring of biologics. Eliminates analyte-to-metal surface interactions greatly enhancing recovery of hard-to-detect ...
Nasdaq

Waters Peptide Multi-Attribute Method for BioAccord System Boosts Innovator and Biosimilar Drug Development and Commercialization

New Peptide MAM (multi-attribute method) workflow for the BioAccord LC-MS System monitors product quality attributes that can affect efficacy and safety of innovator drugs and biosimilars. End-to-end ...
Nasdaq

Waters (WAT) BioAccord System to Expand Portfolio Offerings

Waters Corporation WAT launched an integrated high-resolution liquid chromatography mass spectrometry (LC-MS) system, namely the Waters BioAccord System with ACQUITY Premier. The BioAccord System ...
Business Insider

Waters Corporation Lauded by Frost & Sullivan for Developing the First Truly Smart Mass Spectrometer, the BioAccord LC-MS System

The system was designed to enhance productivity, positioning the user to acquire and process data with a purpose-built LC-MS platform SANTA CLARA, Calif., Jan. 8, 2020 /CNW/ -- Based on its analysis ...
The Korea Herald

Waters Launches New Walk-up Solutions that Further Simplify the Analysis of Biologic Drug Product and Cell Culture Media

MILFORD, Mass., Sept. 12, 2023 /PRNewswire/ -- Waters Corporation (WAT:NYSE) announced new bioprocess walk-up solutions designed to further simplify biologic sample prep and analysis. By eliminating ...